Next Science (ASX:NXS) Dividend Yield % : 0.00% (As of Jun. 07, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Next Science Dividend Yield %?

As of today (2024-06-07), the Trailing Annual Dividend Yield of Next Science is 0.00%.

The historical rank and industry rank for Next Science's Dividend Yield % or its related term are showing as below:

ASX:NXS's Dividend Yield % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 1.83
* Ranked among companies with meaningful Dividend Yield % only.

Next Science's Dividend Payout Ratio for the six months ended in Dec. 2023 was 0.00.

As of today (2024-06-07), the Forward Dividend Yield % of Next Science is 0.00%.

Next Science's Dividends per Share for the six months ended in Dec. 2023 was A$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Next Science Dividend Yield % Historical Data

The historical data trend for Next Science's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Next Science Dividend Yield % Chart

Next Science Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividend Yield %

Get a 7-Day Free Trial

Next Science Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Dividend Yield %	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of Next Science's Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Next Science's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Next Science's Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Next Science's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Next Science's Dividend Yield % falls into.

Next Science Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Next Science (ASX:NXS) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Next Science Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Next Science's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Next Science (ASX:NXS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Next Science Ltd (ASX:NXS) » Definitions » Dividend Yield %

Comparable Companies

Traded in Other Exchanges

NXSCF:USA

Address

821 Pacific Highway, Suite 1902, Level 19, Tower A, The Zenith Building, Chatswood, NSW, AUS, 2067

Website

https://www.nextscience.com

Next Science Ltd is a medical technology company. It is engaged in the development and commercialization of its proprietary Xbio technology to reduce the impact of biofilm-based infections in human health. Xbio is a non-toxic technology with proven efficacy in eradicating both biofilm based and free-floating bacteria. Its products include Bactisure, SURGX, XEPERIENCE and BLASTX. The company derives revenue from the U.S. and Australia, of which prime revenue is derived from the U.S.

Next Science (ASX:NXS) Headlines

No Headlines